info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143875 |
| CAS No | NA |
| Mol.F. | C23H30N2O4 |
| Mol.Wt. | 398.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143876 |
| CAS No | NA |
| Mol.F. | C36H62N2O13 |
| Mol.Wt. | 730.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143877 |
| CAS No | NA |
| Mol.F. | C36H65N3O14 |
| Mol.Wt. | 763.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143878 |
| CAS No | NA |
| Mol.F. | C36H64N2O14 |
| Mol.Wt. | 748.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143879 |
| CAS No | NA |
| Mol.F. | C9H12N2O3 |
| Mol.Wt. | 196.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143880 |
| CAS No | NA |
| Mol.F. | C25H21N5O5 |
| Mol.Wt. | 471.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143881 |
| CAS No | NA |
| Mol.F. | C28H28N6O5 |
| Mol.Wt. | 528.57g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143882 |
| CAS No | NA |
| Mol.F. | C12H13N3O2 |
| Mol.Wt. | 231.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143883 |
| CAS No | NA |
| Mol.F. | C11H18N6O3S2 |
| Mol.Wt. | 346.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143884 |
| CAS No | NA |
| Mol.F. | C4H8N4O3 |
| Mol.Wt. | 160.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143885 |
| CAS No | NA |
| Mol.F. | C4H7N3O3S |
| Mol.Wt. | 177.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143886 |
| CAS No | NA |
| Mol.F. | C12H20N6O4S2 |
| Mol.Wt. | 376.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143887 |
| CAS No | NA |
| Mol.F. | C11H17N5O4S2 |
| Mol.Wt. | 347.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143888 |
| CAS No | NA |
| Mol.F. | C15H24N8O5S3 |
| Mol.Wt. | 492.59 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143889 |
| CAS No | NA |
| Mol.F. | C20H32N8O3S4 |
| Mol.Wt. | 560.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143890 |
| CAS No | NA |
| Mol.F. | C11H19N5O2S2 |
| Mol.Wt. | 317.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
